Comparison of Pantoprazole 20 mg to Ranitidine 150 mg b.i.d. in the Treatment of Mild Gastroesophageal Reflux Disease

Publisher： Karger

E-ISSN： 1421-9867|63|3|163-170

ISSN： 0012-2823

Source： Digestion, Vol.63, Iss.3, 2001-05, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Pantoprazole versus Ranitidine in the Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease

By  

Digestion, Vol. 70, Iss. 1, 2004-09 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

On-Demand Therapy with Pantoprazole 20 mg as Effective Long-Term Management of Reflux Disease in Patients with Mild GERD: The ORION Trial

By  

Digestion, Vol. 72, Iss. 2-3, 2005-10 ,pp. : 76-85

Karger

Access to resources Recommend Favorite

Pantoprazole 40 mg Is as Effective as Esomeprazole 40 mg to Relieve Symptoms of Gastroesophageal Reflux Disease after 4 Weeks of Treatment and Superior regarding the Prevention of Symptomatic Relapse

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 69-78

Karger

Access to resources Recommend Favorite

Pantoprazole 40 mg Is as Effective as Esomeprazole 40 mg to Relieve Symptoms of Gastroesophageal Reflux Disease after 4 Weeks of Treatment and Superior regarding the Prevention of Symptomatic Relapse

By  

Digestion, Vol. 74, Iss. 3-4, 2007-04 ,pp. : 145-154

Karger

Access to resources Recommend Favorite

Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial

By Pratha Vijaya   Hogan Daniel   Lynn Richard   Field Brian   Metz David  

Digestive Diseases and Sciences, Vol. 51, Iss. 9, 2006-09 ,pp. : 1595-1601

Springer Publishing Company

Access to resources Recommend Favorite